Legal Developments

An illustration of a gavel, representing legal coverage on MedTruth.

The justice system plays an essential role in the safety of prescription drugs and medical devices. When regulatory agencies fail to act, a courthouse becomes the only way to hold manufacturers accountable. At MedTruth, we believe the vitality of a nation relies on the justice upheld by its people. Keep your hand on the pulse of mass torts law and other litigation regarding patient harm and consumer safety.

Top Articles on Legal Developments

Wildfires burning in California potentially caused by PG&E

California Wildfires Spark Legal and Political Battles for PG&E

Nicole Knight · December 5, 2019

PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.

Legal Developments
A photo of plants, representing the concept of Roundup causing cancer.

In 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer

Emma Schkloven · November 26, 2019

The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.

Legal Developments
A photo of J&J's talcum powder products in relation to a recent lawsuit involving Claire's.

Seven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others

James Parker · August 1, 2019

Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.

Legal Developments
Pregnant woman taking Zofran for nausea representing the 500 cases pending against GlaxoSmithKline.

Hundreds of Cases Against Zofran Manufacturer Still Pending

Nicole Knight · March 13, 2020

More than 500 cases are pending against GlaxoSmithKline, claiming the drugmaker aggressively marketed Zofran to pregnant women without informing them of the potential risk of birth defects.

Legal Developments
Pregnant woman taking Zofran for nausea representing the 500 cases pending against GlaxoSmithKline.

Hundreds of Cases Against Zofran Manufacturer Still Pending

Nicole Knight · March 13, 2020

More than 500 cases are pending against GlaxoSmithKline, claiming the drugmaker aggressively marketed Zofran to pregnant women without informing them of the potential risk of birth defects.

Legal Developments
Pregnant woman taking Zofran for nausea representing the 500 cases pending against GlaxoSmithKline.

Hundreds of Cases Against Zofran Manufacturer Still Pending

Nicole Knight · March 13, 2020

More than 500 cases are pending against GlaxoSmithKline, claiming the drugmaker aggressively marketed Zofran to pregnant women without informing them of the potential risk of birth defects.

Legal Developments
Pregnant woman taking Zofran for nausea representing the 500 cases pending against GlaxoSmithKline.

Hundreds of Cases Against Zofran Manufacturer Still Pending

Nicole Knight · March 13, 2020

More than 500 cases are pending against GlaxoSmithKline, claiming the drugmaker aggressively marketed Zofran to pregnant women without informing them of the potential risk of birth defects.

Legal Developments
Pregnant woman taking Zofran for nausea representing the 500 cases pending against GlaxoSmithKline.

Hundreds of Cases Against Zofran Manufacturer Still Pending

Nicole Knight · March 13, 2020

More than 500 cases are pending against GlaxoSmithKline, claiming the drugmaker aggressively marketed Zofran to pregnant women without informing them of the potential risk of birth defects.

Legal Developments
Pregnant woman taking Zofran for nausea representing the 500 cases pending against GlaxoSmithKline.

Hundreds of Cases Against Zofran Manufacturer Still Pending

Nicole Knight · March 13, 2020

More than 500 cases are pending against GlaxoSmithKline, claiming the drugmaker aggressively marketed Zofran to pregnant women without informing them of the potential risk of birth defects.

Legal Developments
Pregnant woman taking Zofran for nausea representing the 500 cases pending against GlaxoSmithKline.

Hundreds of Cases Against Zofran Manufacturer Still Pending

Nicole Knight · March 13, 2020

More than 500 cases are pending against GlaxoSmithKline, claiming the drugmaker aggressively marketed Zofran to pregnant women without informing them of the potential risk of birth defects.

Legal Developments
Pregnant woman taking Zofran for nausea representing the 500 cases pending against GlaxoSmithKline.

Hundreds of Cases Against Zofran Manufacturer Still Pending

Nicole Knight · March 13, 2020

More than 500 cases are pending against GlaxoSmithKline, claiming the drugmaker aggressively marketed Zofran to pregnant women without informing them of the potential risk of birth defects.

Legal Developments
A photo of a young hand holding a JUUL e-cigarette.

More States Sue JUUL As FDA's Regulatory Deadline Approaches

Kimberly Nicoletti · March 11, 2020

As more states file suit against Juul, the vaping manufacturer prepares to submit an application to the FDA to prove that e-cigarettes benefit smokers more than they harm teenagers.

Legal Developments
A photo of a young hand holding a JUUL e-cigarette.

More States Sue JUUL As FDA's Regulatory Deadline Approaches

Kimberly Nicoletti · March 11, 2020

As more states file suit against Juul, the vaping manufacturer prepares to submit an application to the FDA to prove that e-cigarettes benefit smokers more than they harm teenagers.

Legal Developments
A photo of a young hand holding a JUUL e-cigarette.

More States Sue JUUL As FDA's Regulatory Deadline Approaches

Kimberly Nicoletti · March 11, 2020

As more states file suit against Juul, the vaping manufacturer prepares to submit an application to the FDA to prove that e-cigarettes benefit smokers more than they harm teenagers.

Legal Developments
A photo of a young hand holding a JUUL e-cigarette.

More States Sue JUUL As FDA's Regulatory Deadline Approaches

Kimberly Nicoletti · March 11, 2020

As more states file suit against Juul, the vaping manufacturer prepares to submit an application to the FDA to prove that e-cigarettes benefit smokers more than they harm teenagers.

Legal Developments
A photo of a young hand holding a JUUL e-cigarette.

More States Sue JUUL As FDA's Regulatory Deadline Approaches

Kimberly Nicoletti · March 11, 2020

As more states file suit against Juul, the vaping manufacturer prepares to submit an application to the FDA to prove that e-cigarettes benefit smokers more than they harm teenagers.

Legal Developments
A photo of a young hand holding a JUUL e-cigarette.

More States Sue JUUL As FDA's Regulatory Deadline Approaches

Kimberly Nicoletti · March 11, 2020

As more states file suit against Juul, the vaping manufacturer prepares to submit an application to the FDA to prove that e-cigarettes benefit smokers more than they harm teenagers.

Legal Developments
A photo of a young hand holding a JUUL e-cigarette.

More States Sue JUUL As FDA's Regulatory Deadline Approaches

Kimberly Nicoletti · March 11, 2020

As more states file suit against Juul, the vaping manufacturer prepares to submit an application to the FDA to prove that e-cigarettes benefit smokers more than they harm teenagers.

Legal Developments
A photo of a young hand holding a JUUL e-cigarette.

More States Sue JUUL As FDA's Regulatory Deadline Approaches

Kimberly Nicoletti · March 11, 2020

As more states file suit against Juul, the vaping manufacturer prepares to submit an application to the FDA to prove that e-cigarettes benefit smokers more than they harm teenagers.

Legal Developments
Man holding white pills representing Zantac multidistrict litigation.

Corporations Accused of Allowing Excess NDMA in Zantac MDL

James Parker · March 4, 2020

A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.

Legal Developments
Man holding white pills representing Zantac multidistrict litigation.

Corporations Accused of Allowing Excess NDMA in Zantac MDL

James Parker · March 4, 2020

A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.

Legal Developments
Man holding white pills representing Zantac multidistrict litigation.

Corporations Accused of Allowing Excess NDMA in Zantac MDL

James Parker · March 4, 2020

A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.

Legal Developments
Man holding white pills representing Zantac multidistrict litigation.

Corporations Accused of Allowing Excess NDMA in Zantac MDL

James Parker · March 4, 2020

A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.

Legal Developments
Man holding white pills representing Zantac multidistrict litigation.

Corporations Accused of Allowing Excess NDMA in Zantac MDL

James Parker · March 4, 2020

A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.

Legal Developments
Man holding white pills representing Zantac multidistrict litigation.

Corporations Accused of Allowing Excess NDMA in Zantac MDL

James Parker · March 4, 2020

A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.

Legal Developments
Man holding white pills representing Zantac multidistrict litigation.

Corporations Accused of Allowing Excess NDMA in Zantac MDL

James Parker · March 4, 2020

A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.

Legal Developments
Man holding white pills representing Zantac multidistrict litigation.

Corporations Accused of Allowing Excess NDMA in Zantac MDL

James Parker · March 4, 2020

A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.

Legal Developments
A photo of money, representing the February 2020 J&J talc fine.

J&J Fined More Than $180 Million for Asbestos Contamination

James Parker · February 6, 2020

A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.

Legal Developments

National Trial Lawyers Summit Hosts First-Ever Women's Leadership Forum

Andrea Sarcos · February 6, 2020

Nearly 50 trial lawyers gathered at the Women’s Leadership Forum, a dedicated development session in support of women in the profession, at the National Trial Lawyers Summit in Miami, Florida.

Legal Developments
A photo of money, representing the February 2020 J&J talc fine.

J&J Fined More Than $180 Million for Asbestos Contamination

James Parker · February 6, 2020

A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.

Legal Developments
A photo of money, representing the February 2020 J&J talc fine.

J&J Fined More Than $180 Million for Asbestos Contamination

James Parker · February 6, 2020

A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.

Legal Developments
A photo of money, representing the February 2020 J&J talc fine.

J&J Fined More Than $180 Million for Asbestos Contamination

James Parker · February 6, 2020

A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.

Legal Developments

National Trial Lawyers Summit Hosts First-Ever Women's Leadership Forum

Andrea Sarcos · February 6, 2020

Nearly 50 trial lawyers gathered at the Women’s Leadership Forum, a dedicated development session in support of women in the profession, at the National Trial Lawyers Summit in Miami, Florida.

Legal Developments

National Trial Lawyers Summit Hosts First-Ever Women's Leadership Forum

Andrea Sarcos · February 6, 2020

Nearly 50 trial lawyers gathered at the Women’s Leadership Forum, a dedicated development session in support of women in the profession, at the National Trial Lawyers Summit in Miami, Florida.

Legal Developments

National Trial Lawyers Summit Hosts First-Ever Women's Leadership Forum

Andrea Sarcos · February 6, 2020

Nearly 50 trial lawyers gathered at the Women’s Leadership Forum, a dedicated development session in support of women in the profession, at the National Trial Lawyers Summit in Miami, Florida.

Legal Developments

National Trial Lawyers Summit Hosts First-Ever Women's Leadership Forum

Andrea Sarcos · February 6, 2020

Nearly 50 trial lawyers gathered at the Women’s Leadership Forum, a dedicated development session in support of women in the profession, at the National Trial Lawyers Summit in Miami, Florida.

Legal Developments
A photo of money, representing the February 2020 J&J talc fine.

J&J Fined More Than $180 Million for Asbestos Contamination

James Parker · February 6, 2020

A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.

Legal Developments

National Trial Lawyers Summit Hosts First-Ever Women's Leadership Forum

Andrea Sarcos · February 6, 2020

Nearly 50 trial lawyers gathered at the Women’s Leadership Forum, a dedicated development session in support of women in the profession, at the National Trial Lawyers Summit in Miami, Florida.

Legal Developments
A photo of money, representing the February 2020 J&J talc fine.

J&J Fined More Than $180 Million for Asbestos Contamination

James Parker · February 6, 2020

A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.

Legal Developments

National Trial Lawyers Summit Hosts First-Ever Women's Leadership Forum

Andrea Sarcos · February 6, 2020

Nearly 50 trial lawyers gathered at the Women’s Leadership Forum, a dedicated development session in support of women in the profession, at the National Trial Lawyers Summit in Miami, Florida.

Legal Developments

National Trial Lawyers Summit Hosts First-Ever Women's Leadership Forum

Andrea Sarcos · February 6, 2020

Nearly 50 trial lawyers gathered at the Women’s Leadership Forum, a dedicated development session in support of women in the profession, at the National Trial Lawyers Summit in Miami, Florida.

Legal Developments
A photo of money, representing the February 2020 J&J talc fine.

J&J Fined More Than $180 Million for Asbestos Contamination

James Parker · February 6, 2020

A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.

Legal Developments
A photo of money, representing the February 2020 J&J talc fine.

J&J Fined More Than $180 Million for Asbestos Contamination

James Parker · February 6, 2020

A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.

Legal Developments
A stock photo of a judge writing a decision, representing the January 2020 Ethicon mesh judgement in California.

California Ethicon Mesh Judgement Results in $344 Million Fine for J&J

James Parker · January 30, 2020

Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.

Legal Developments
A stock photo of a judge writing a decision, representing the January 2020 Ethicon mesh judgement in California.

California Ethicon Mesh Judgement Results in $344 Million Fine for J&J

James Parker · January 30, 2020

Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.

Legal Developments
A stock photo of a judge writing a decision, representing the January 2020 Ethicon mesh judgement in California.

California Ethicon Mesh Judgement Results in $344 Million Fine for J&J

James Parker · January 30, 2020

Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.

Legal Developments
A stock photo of a judge writing a decision, representing the January 2020 Ethicon mesh judgement in California.

California Ethicon Mesh Judgement Results in $344 Million Fine for J&J

James Parker · January 30, 2020

Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.

Legal Developments
A stock photo of a judge writing a decision, representing the January 2020 Ethicon mesh judgement in California.

California Ethicon Mesh Judgement Results in $344 Million Fine for J&J

James Parker · January 30, 2020

Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.

Legal Developments
A stock photo of a judge writing a decision, representing the January 2020 Ethicon mesh judgement in California.

California Ethicon Mesh Judgement Results in $344 Million Fine for J&J

James Parker · January 30, 2020

Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.

Legal Developments
A stock photo of a judge writing a decision, representing the January 2020 Ethicon mesh judgement in California.

California Ethicon Mesh Judgement Results in $344 Million Fine for J&J

James Parker · January 30, 2020

Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.

Legal Developments
A stock photo of a judge writing a decision, representing the January 2020 Ethicon mesh judgement in California.

California Ethicon Mesh Judgement Results in $344 Million Fine for J&J

James Parker · January 30, 2020

Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.

Legal Developments
A photo of a file of legal complaint, representing the Boynton Beach Zantac lawsuit.

Boynton Beach Zantac Lawsuit Filed by Local Woman

James Parker · January 15, 2020

A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.

Legal Developments
A photo of a file of legal complaint, representing the Boynton Beach Zantac lawsuit.

Boynton Beach Zantac Lawsuit Filed by Local Woman

James Parker · January 15, 2020

A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.

Legal Developments
A photo of a file of legal complaint, representing the Boynton Beach Zantac lawsuit.

Boynton Beach Zantac Lawsuit Filed by Local Woman

James Parker · January 15, 2020

A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.

Legal Developments
A photo of a file of legal complaint, representing the Boynton Beach Zantac lawsuit.

Boynton Beach Zantac Lawsuit Filed by Local Woman

James Parker · January 15, 2020

A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.

Legal Developments
A photo of a file of legal complaint, representing the Boynton Beach Zantac lawsuit.

Boynton Beach Zantac Lawsuit Filed by Local Woman

James Parker · January 15, 2020

A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.

Legal Developments
A photo of a file of legal complaint, representing the Boynton Beach Zantac lawsuit.

Boynton Beach Zantac Lawsuit Filed by Local Woman

James Parker · January 15, 2020

A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.

Legal Developments
A photo of a file of legal complaint, representing the Boynton Beach Zantac lawsuit.

Boynton Beach Zantac Lawsuit Filed by Local Woman

James Parker · January 15, 2020

A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.

Legal Developments
A photo of a file of legal complaint, representing the Boynton Beach Zantac lawsuit.

Boynton Beach Zantac Lawsuit Filed by Local Woman

James Parker · January 15, 2020

A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.

Legal Developments
A stock photo of a woman signing a document, representing the recent midtrial settlement in the California talcum powder mesothelioma case.

Johnson & Johnson Settlement Abruptly Concludes California Talc Trial

James Parker · January 7, 2020

Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.

Legal Developments
A stock photo of a woman signing a document, representing the recent midtrial settlement in the California talcum powder mesothelioma case.

Johnson & Johnson Settlement Abruptly Concludes California Talc Trial

James Parker · January 7, 2020

Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.

Legal Developments
A stock photo of a woman signing a document, representing the recent midtrial settlement in the California talcum powder mesothelioma case.

Johnson & Johnson Settlement Abruptly Concludes California Talc Trial

James Parker · January 7, 2020

Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.

Legal Developments
A stock photo of a woman signing a document, representing the recent midtrial settlement in the California talcum powder mesothelioma case.

Johnson & Johnson Settlement Abruptly Concludes California Talc Trial

James Parker · January 7, 2020

Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.

Legal Developments
A stock photo of a woman signing a document, representing the recent midtrial settlement in the California talcum powder mesothelioma case.

Johnson & Johnson Settlement Abruptly Concludes California Talc Trial

James Parker · January 7, 2020

Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.

Legal Developments
A stock photo of a woman signing a document, representing the recent midtrial settlement in the California talcum powder mesothelioma case.

Johnson & Johnson Settlement Abruptly Concludes California Talc Trial

James Parker · January 7, 2020

Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.

Legal Developments
A stock photo of a woman signing a document, representing the recent midtrial settlement in the California talcum powder mesothelioma case.

Johnson & Johnson Settlement Abruptly Concludes California Talc Trial

James Parker · January 7, 2020

Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.

Legal Developments
A stock photo of a woman signing a document, representing the recent midtrial settlement in the California talcum powder mesothelioma case.

Johnson & Johnson Settlement Abruptly Concludes California Talc Trial

James Parker · January 7, 2020

Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.

Legal Developments
A photo of a justice scale representing the Los Angeles jury verdict which found in favor of Johnson & Johnson in a recent mesothelioma cancer case.

Los Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit

James Parker · December 17, 2019

A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.

Legal Developments
A photo of a justice scale representing the Los Angeles jury verdict which found in favor of Johnson & Johnson in a recent mesothelioma cancer case.

Los Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit

James Parker · December 17, 2019

A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.

Legal Developments
Fields in Maui where Monsanto illegally sprayed banned pesticides.

Monsanto Loses $10 Million in Maui Pesticide Case

Emma Schkloven · December 17, 2019

Monsanto pleaded guilty to spraying illegal pesticides in Maui, Hawaii, and has agreed to pay $10 million in charges.

Legal Developments
A photo of a justice scale representing the Los Angeles jury verdict which found in favor of Johnson & Johnson in a recent mesothelioma cancer case.

Los Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit

James Parker · December 17, 2019

A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.

Legal Developments
Fields in Maui where Monsanto illegally sprayed banned pesticides.

Monsanto Loses $10 Million in Maui Pesticide Case

Emma Schkloven · December 17, 2019

Monsanto pleaded guilty to spraying illegal pesticides in Maui, Hawaii, and has agreed to pay $10 million in charges.

Legal Developments
Fields in Maui where Monsanto illegally sprayed banned pesticides.

Monsanto Loses $10 Million in Maui Pesticide Case

Emma Schkloven · December 17, 2019

Monsanto pleaded guilty to spraying illegal pesticides in Maui, Hawaii, and has agreed to pay $10 million in charges.

Legal Developments
Fields in Maui where Monsanto illegally sprayed banned pesticides.

Monsanto Loses $10 Million in Maui Pesticide Case

Emma Schkloven · December 17, 2019

Monsanto pleaded guilty to spraying illegal pesticides in Maui, Hawaii, and has agreed to pay $10 million in charges.

Legal Developments
Fields in Maui where Monsanto illegally sprayed banned pesticides.

Monsanto Loses $10 Million in Maui Pesticide Case

Emma Schkloven · December 17, 2019

Monsanto pleaded guilty to spraying illegal pesticides in Maui, Hawaii, and has agreed to pay $10 million in charges.

Legal Developments
Fields in Maui where Monsanto illegally sprayed banned pesticides.

Monsanto Loses $10 Million in Maui Pesticide Case

Emma Schkloven · December 17, 2019

Monsanto pleaded guilty to spraying illegal pesticides in Maui, Hawaii, and has agreed to pay $10 million in charges.

Legal Developments
A photo of a justice scale representing the Los Angeles jury verdict which found in favor of Johnson & Johnson in a recent mesothelioma cancer case.

Los Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit

James Parker · December 17, 2019

A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.

Legal Developments
Fields in Maui where Monsanto illegally sprayed banned pesticides.

Monsanto Loses $10 Million in Maui Pesticide Case

Emma Schkloven · December 17, 2019

Monsanto pleaded guilty to spraying illegal pesticides in Maui, Hawaii, and has agreed to pay $10 million in charges.

Legal Developments
A photo of a justice scale representing the Los Angeles jury verdict which found in favor of Johnson & Johnson in a recent mesothelioma cancer case.

Los Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit

James Parker · December 17, 2019

A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.

Legal Developments
A photo of a justice scale representing the Los Angeles jury verdict which found in favor of Johnson & Johnson in a recent mesothelioma cancer case.

Los Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit

James Parker · December 17, 2019

A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.

Legal Developments
A photo of a justice scale representing the Los Angeles jury verdict which found in favor of Johnson & Johnson in a recent mesothelioma cancer case.

Los Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit

James Parker · December 17, 2019

A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.

Legal Developments
Fields in Maui where Monsanto illegally sprayed banned pesticides.

Monsanto Loses $10 Million in Maui Pesticide Case

Emma Schkloven · December 17, 2019

Monsanto pleaded guilty to spraying illegal pesticides in Maui, Hawaii, and has agreed to pay $10 million in charges.

Legal Developments
A photo of a justice scale representing the Los Angeles jury verdict which found in favor of Johnson & Johnson in a recent mesothelioma cancer case.

Los Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit

James Parker · December 17, 2019

A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.

Legal Developments
A photo of a woman considering getting breast implants, and a surgeon failing to explain the risks.

Women Sue Allergan for Concealing Breast Implant Cancer Risk

Nicole Knight · December 6, 2019

Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.

Legal Developments
A photo of a woman considering getting breast implants, and a surgeon failing to explain the risks.

Women Sue Allergan for Concealing Breast Implant Cancer Risk

Nicole Knight · December 6, 2019

Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.

Legal Developments
A photo of a woman considering getting breast implants, and a surgeon failing to explain the risks.

Women Sue Allergan for Concealing Breast Implant Cancer Risk

Nicole Knight · December 6, 2019

Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.

Legal Developments
A photo of a woman considering getting breast implants, and a surgeon failing to explain the risks.

Women Sue Allergan for Concealing Breast Implant Cancer Risk

Nicole Knight · December 6, 2019

Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.

Legal Developments
A photo of a woman considering getting breast implants, and a surgeon failing to explain the risks.

Women Sue Allergan for Concealing Breast Implant Cancer Risk

Nicole Knight · December 6, 2019

Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.

Legal Developments
A photo of a woman considering getting breast implants, and a surgeon failing to explain the risks.

Women Sue Allergan for Concealing Breast Implant Cancer Risk

Nicole Knight · December 6, 2019

Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.

Legal Developments
A photo of a woman considering getting breast implants, and a surgeon failing to explain the risks.

Women Sue Allergan for Concealing Breast Implant Cancer Risk

Nicole Knight · December 6, 2019

Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.

Legal Developments
A photo of a woman considering getting breast implants, and a surgeon failing to explain the risks.

Women Sue Allergan for Concealing Breast Implant Cancer Risk

Nicole Knight · December 6, 2019

Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.

Legal Developments
Wildfires burning in California potentially caused by PG&E

California Wildfires Spark Legal and Political Battles for PG&E

Nicole Knight · December 5, 2019

PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.

Legal Developments
Wildfires burning in California potentially caused by PG&E

California Wildfires Spark Legal and Political Battles for PG&E

Nicole Knight · December 5, 2019

PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.

Legal Developments
Wildfires burning in California potentially caused by PG&E

California Wildfires Spark Legal and Political Battles for PG&E

Nicole Knight · December 5, 2019

PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.

Legal Developments
Wildfires burning in California potentially caused by PG&E

California Wildfires Spark Legal and Political Battles for PG&E

Nicole Knight · December 5, 2019

PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.

Legal Developments
Wildfires burning in California potentially caused by PG&E

California Wildfires Spark Legal and Political Battles for PG&E

Nicole Knight · December 5, 2019

PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.

Legal Developments
Wildfires burning in California potentially caused by PG&E

California Wildfires Spark Legal and Political Battles for PG&E

Nicole Knight · December 5, 2019

PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.

Legal Developments
Wildfires burning in California potentially caused by PG&E

California Wildfires Spark Legal and Political Battles for PG&E

Nicole Knight · December 5, 2019

PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.

Legal Developments
Wildfires burning in California potentially caused by PG&E

California Wildfires Spark Legal and Political Battles for PG&E

Nicole Knight · December 5, 2019

PG&E, the power provider implicated in the recent California wildfires, now faces legal action by the state.

Legal Developments
A photo of plants, representing the concept of Roundup causing cancer.

In 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer

Emma Schkloven · November 26, 2019

The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.

Legal Developments
A photo of plants, representing the concept of Roundup causing cancer.

In 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer

Emma Schkloven · November 26, 2019

The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.

Legal Developments
A photo of plants, representing the concept of Roundup causing cancer.

In 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer

Emma Schkloven · November 26, 2019

The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.

Legal Developments
A photo of plants, representing the concept of Roundup causing cancer.

In 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer

Emma Schkloven · November 26, 2019

The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.

Legal Developments
A photo of plants, representing the concept of Roundup causing cancer.

In 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer

Emma Schkloven · November 26, 2019

The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.

Legal Developments
A photo of plants, representing the concept of Roundup causing cancer.

In 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer

Emma Schkloven · November 26, 2019

The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.

Legal Developments
A photo of plants, representing the concept of Roundup causing cancer.

In 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer

Emma Schkloven · November 26, 2019

The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.

Legal Developments
A photo of plants, representing the concept of Roundup causing cancer.

In 3 Months, 20,000 More Plaintiffs Claim Roundup Caused Cancer

Emma Schkloven · November 26, 2019

The number of plaintiffs claiming Roundup caused their cancer has more than doubled to 42,700 in the last three months.

Legal Developments
Photo of land in Hawaii to represent Maui Families Suing Monsanto for in-utero chemical exposure

Maui Families File Suit Against Monsanto for Chemical Exposure

Emma Schkloven · November 19, 2019

Two families in Maui, Hawaii, have filed a lawsuit against Monsanto, claiming the company’s use of pesticides and chemicals led to birth defects in their newborns. 

Legal Developments
Photo of land in Hawaii to represent Maui Families Suing Monsanto for in-utero chemical exposure

Maui Families File Suit Against Monsanto for Chemical Exposure

Emma Schkloven · November 19, 2019

Two families in Maui, Hawaii, have filed a lawsuit against Monsanto, claiming the company’s use of pesticides and chemicals led to birth defects in their newborns. 

Legal Developments
Photo of land in Hawaii to represent Maui Families Suing Monsanto for in-utero chemical exposure

Maui Families File Suit Against Monsanto for Chemical Exposure

Emma Schkloven · November 19, 2019

Two families in Maui, Hawaii, have filed a lawsuit against Monsanto, claiming the company’s use of pesticides and chemicals led to birth defects in their newborns. 

Legal Developments
Photo of land in Hawaii to represent Maui Families Suing Monsanto for in-utero chemical exposure

Maui Families File Suit Against Monsanto for Chemical Exposure

Emma Schkloven · November 19, 2019

Two families in Maui, Hawaii, have filed a lawsuit against Monsanto, claiming the company’s use of pesticides and chemicals led to birth defects in their newborns. 

Legal Developments
Photo of land in Hawaii to represent Maui Families Suing Monsanto for in-utero chemical exposure

Maui Families File Suit Against Monsanto for Chemical Exposure

Emma Schkloven · November 19, 2019

Two families in Maui, Hawaii, have filed a lawsuit against Monsanto, claiming the company’s use of pesticides and chemicals led to birth defects in their newborns. 

Legal Developments
Photo of land in Hawaii to represent Maui Families Suing Monsanto for in-utero chemical exposure

Maui Families File Suit Against Monsanto for Chemical Exposure

Emma Schkloven · November 19, 2019

Two families in Maui, Hawaii, have filed a lawsuit against Monsanto, claiming the company’s use of pesticides and chemicals led to birth defects in their newborns. 

Legal Developments
Photo of land in Hawaii to represent Maui Families Suing Monsanto for in-utero chemical exposure

Maui Families File Suit Against Monsanto for Chemical Exposure

Emma Schkloven · November 19, 2019

Two families in Maui, Hawaii, have filed a lawsuit against Monsanto, claiming the company’s use of pesticides and chemicals led to birth defects in their newborns. 

Legal Developments
Photo of land in Hawaii to represent Maui Families Suing Monsanto for in-utero chemical exposure

Maui Families File Suit Against Monsanto for Chemical Exposure

Emma Schkloven · November 19, 2019

Two families in Maui, Hawaii, have filed a lawsuit against Monsanto, claiming the company’s use of pesticides and chemicals led to birth defects in their newborns. 

Legal Developments
Doctor charged in transvaginal mesh surgery scheme consulting with patient.

Doctor and Accomplice Charged in Transvaginal Mesh Surgery Scheme

Nicole Knight · November 14, 2019

A doctor and his consultant face multiple charges after tricking transvaginal mesh patients into getting unnecessary surgery.

Legal Developments
Doctor charged in transvaginal mesh surgery scheme consulting with patient.

Doctor and Accomplice Charged in Transvaginal Mesh Surgery Scheme

Nicole Knight · November 14, 2019

A doctor and his consultant face multiple charges after tricking transvaginal mesh patients into getting unnecessary surgery.

Legal Developments
Doctor charged in transvaginal mesh surgery scheme consulting with patient.

Doctor and Accomplice Charged in Transvaginal Mesh Surgery Scheme

Nicole Knight · November 14, 2019

A doctor and his consultant face multiple charges after tricking transvaginal mesh patients into getting unnecessary surgery.

Legal Developments
Doctor charged in transvaginal mesh surgery scheme consulting with patient.

Doctor and Accomplice Charged in Transvaginal Mesh Surgery Scheme

Nicole Knight · November 14, 2019

A doctor and his consultant face multiple charges after tricking transvaginal mesh patients into getting unnecessary surgery.

Legal Developments
Doctor charged in transvaginal mesh surgery scheme consulting with patient.

Doctor and Accomplice Charged in Transvaginal Mesh Surgery Scheme

Nicole Knight · November 14, 2019

A doctor and his consultant face multiple charges after tricking transvaginal mesh patients into getting unnecessary surgery.

Legal Developments
Doctor charged in transvaginal mesh surgery scheme consulting with patient.

Doctor and Accomplice Charged in Transvaginal Mesh Surgery Scheme

Nicole Knight · November 14, 2019

A doctor and his consultant face multiple charges after tricking transvaginal mesh patients into getting unnecessary surgery.

Legal Developments
Doctor charged in transvaginal mesh surgery scheme consulting with patient.

Doctor and Accomplice Charged in Transvaginal Mesh Surgery Scheme

Nicole Knight · November 14, 2019

A doctor and his consultant face multiple charges after tricking transvaginal mesh patients into getting unnecessary surgery.

Legal Developments
Doctor charged in transvaginal mesh surgery scheme consulting with patient.

Doctor and Accomplice Charged in Transvaginal Mesh Surgery Scheme

Nicole Knight · November 14, 2019

A doctor and his consultant face multiple charges after tricking transvaginal mesh patients into getting unnecessary surgery.

Legal Developments
Photo of baby feet to suggest birth defects in Zofran litigation which are being disputed, despite removal of one supplemental study in October

Birth Defects in Zofran Litigation Disputed, Despite Evidence Removed

James Parker · November 13, 2019

Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.

Legal Developments
Photo of baby feet to suggest birth defects in Zofran litigation which are being disputed, despite removal of one supplemental study in October

Birth Defects in Zofran Litigation Disputed, Despite Evidence Removed

James Parker · November 13, 2019

Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.

Legal Developments
Photo of baby feet to suggest birth defects in Zofran litigation which are being disputed, despite removal of one supplemental study in October

Birth Defects in Zofran Litigation Disputed, Despite Evidence Removed

James Parker · November 13, 2019

Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.

Legal Developments
Photo of baby feet to suggest birth defects in Zofran litigation which are being disputed, despite removal of one supplemental study in October

Birth Defects in Zofran Litigation Disputed, Despite Evidence Removed

James Parker · November 13, 2019

Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.

Legal Developments
Photo of baby feet to suggest birth defects in Zofran litigation which are being disputed, despite removal of one supplemental study in October

Birth Defects in Zofran Litigation Disputed, Despite Evidence Removed

James Parker · November 13, 2019

Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.

Legal Developments
Photo of baby feet to suggest birth defects in Zofran litigation which are being disputed, despite removal of one supplemental study in October

Birth Defects in Zofran Litigation Disputed, Despite Evidence Removed

James Parker · November 13, 2019

Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.

Legal Developments
Photo of baby feet to suggest birth defects in Zofran litigation which are being disputed, despite removal of one supplemental study in October

Birth Defects in Zofran Litigation Disputed, Despite Evidence Removed

James Parker · November 13, 2019

Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.

Legal Developments
Photo of baby feet to suggest birth defects in Zofran litigation which are being disputed, despite removal of one supplemental study in October

Birth Defects in Zofran Litigation Disputed, Despite Evidence Removed

James Parker · November 13, 2019

Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.

Legal Developments
A photo of the Supreme Court to represent Riegel v. Medtronic case which set the precedent for lawsuits filed by patients harmed by Class III medical device.

Riegel v. Medtronic: How the Landmark Case Limits Patient Rights

Carah Wertheimer · October 17, 2019

In 2008, a complex case set a legal precedent that dictates how Class III medical devices are approached. It's the landmark Supreme Court ruling, known as Riegel v. Medtronic, that changed everything. Now, those harmed by Class III medical devices struggle to seek legal recourse.

Legal Developments
A photo of the Supreme Court to represent Riegel v. Medtronic case which set the precedent for lawsuits filed by patients harmed by Class III medical device.

Riegel v. Medtronic: How the Landmark Case Limits Patient Rights

Carah Wertheimer · October 17, 2019

In 2008, a complex case set a legal precedent that dictates how Class III medical devices are approached. It's the landmark Supreme Court ruling, known as Riegel v. Medtronic, that changed everything. Now, those harmed by Class III medical devices struggle to seek legal recourse.

Legal Developments
A photo of the Supreme Court to represent Riegel v. Medtronic case which set the precedent for lawsuits filed by patients harmed by Class III medical device.

Riegel v. Medtronic: How the Landmark Case Limits Patient Rights

Carah Wertheimer · October 17, 2019

In 2008, a complex case set a legal precedent that dictates how Class III medical devices are approached. It's the landmark Supreme Court ruling, known as Riegel v. Medtronic, that changed everything. Now, those harmed by Class III medical devices struggle to seek legal recourse.

Legal Developments
A photo of the Supreme Court to represent Riegel v. Medtronic case which set the precedent for lawsuits filed by patients harmed by Class III medical device.

Riegel v. Medtronic: How the Landmark Case Limits Patient Rights

Carah Wertheimer · October 17, 2019

In 2008, a complex case set a legal precedent that dictates how Class III medical devices are approached. It's the landmark Supreme Court ruling, known as Riegel v. Medtronic, that changed everything. Now, those harmed by Class III medical devices struggle to seek legal recourse.

Legal Developments
A photo of the Supreme Court to represent Riegel v. Medtronic case which set the precedent for lawsuits filed by patients harmed by Class III medical device.

Riegel v. Medtronic: How the Landmark Case Limits Patient Rights

Carah Wertheimer · October 17, 2019

In 2008, a complex case set a legal precedent that dictates how Class III medical devices are approached. It's the landmark Supreme Court ruling, known as Riegel v. Medtronic, that changed everything. Now, those harmed by Class III medical devices struggle to seek legal recourse.

Legal Developments
A photo of the Supreme Court to represent Riegel v. Medtronic case which set the precedent for lawsuits filed by patients harmed by Class III medical device.

Riegel v. Medtronic: How the Landmark Case Limits Patient Rights

Carah Wertheimer · October 17, 2019

In 2008, a complex case set a legal precedent that dictates how Class III medical devices are approached. It's the landmark Supreme Court ruling, known as Riegel v. Medtronic, that changed everything. Now, those harmed by Class III medical devices struggle to seek legal recourse.

Legal Developments
A photo of the Supreme Court to represent Riegel v. Medtronic case which set the precedent for lawsuits filed by patients harmed by Class III medical device.

Riegel v. Medtronic: How the Landmark Case Limits Patient Rights

Carah Wertheimer · October 17, 2019

In 2008, a complex case set a legal precedent that dictates how Class III medical devices are approached. It's the landmark Supreme Court ruling, known as Riegel v. Medtronic, that changed everything. Now, those harmed by Class III medical devices struggle to seek legal recourse.

Legal Developments
A photo of the Supreme Court to represent Riegel v. Medtronic case which set the precedent for lawsuits filed by patients harmed by Class III medical device.

Riegel v. Medtronic: How the Landmark Case Limits Patient Rights

Carah Wertheimer · October 17, 2019

In 2008, a complex case set a legal precedent that dictates how Class III medical devices are approached. It's the landmark Supreme Court ruling, known as Riegel v. Medtronic, that changed everything. Now, those harmed by Class III medical devices struggle to seek legal recourse.

Legal Developments
Bottle of opioid pills representing Johnson & Johnson $20.4 million settlement with Ohio Counties

Johnson & Johnson Reached $20.4 Million Settlement With Ohio Counties in Landmark Opioid Case

Tess Francke · October 9, 2019

Johnson & Johnson reached a $20.4 million settlement with Cuyahoga and Summit counties in Ohio. The company resolves all claims by the counties without admission of liability.

Legal Developments
Bottle of opioid pills representing Johnson & Johnson $20.4 million settlement with Ohio Counties

Johnson & Johnson Reached $20.4 Million Settlement With Ohio Counties in Landmark Opioid Case

Tess Francke · October 9, 2019

Johnson & Johnson reached a $20.4 million settlement with Cuyahoga and Summit counties in Ohio. The company resolves all claims by the counties without admission of liability.

Legal Developments
Bottle of opioid pills representing Johnson & Johnson $20.4 million settlement with Ohio Counties

Johnson & Johnson Reached $20.4 Million Settlement With Ohio Counties in Landmark Opioid Case

Tess Francke · October 9, 2019

Johnson & Johnson reached a $20.4 million settlement with Cuyahoga and Summit counties in Ohio. The company resolves all claims by the counties without admission of liability.

Legal Developments
Bottle of opioid pills representing Johnson & Johnson $20.4 million settlement with Ohio Counties

Johnson & Johnson Reached $20.4 Million Settlement With Ohio Counties in Landmark Opioid Case

Tess Francke · October 9, 2019

Johnson & Johnson reached a $20.4 million settlement with Cuyahoga and Summit counties in Ohio. The company resolves all claims by the counties without admission of liability.

Legal Developments
Bottle of opioid pills representing Johnson & Johnson $20.4 million settlement with Ohio Counties

Johnson & Johnson Reached $20.4 Million Settlement With Ohio Counties in Landmark Opioid Case

Tess Francke · October 9, 2019

Johnson & Johnson reached a $20.4 million settlement with Cuyahoga and Summit counties in Ohio. The company resolves all claims by the counties without admission of liability.

Legal Developments
Bottle of opioid pills representing Johnson & Johnson $20.4 million settlement with Ohio Counties

Johnson & Johnson Reached $20.4 Million Settlement With Ohio Counties in Landmark Opioid Case

Tess Francke · October 9, 2019

Johnson & Johnson reached a $20.4 million settlement with Cuyahoga and Summit counties in Ohio. The company resolves all claims by the counties without admission of liability.

Legal Developments
Bottle of opioid pills representing Johnson & Johnson $20.4 million settlement with Ohio Counties

Johnson & Johnson Reached $20.4 Million Settlement With Ohio Counties in Landmark Opioid Case

Tess Francke · October 9, 2019

Johnson & Johnson reached a $20.4 million settlement with Cuyahoga and Summit counties in Ohio. The company resolves all claims by the counties without admission of liability.

Legal Developments
Bottle of opioid pills representing Johnson & Johnson $20.4 million settlement with Ohio Counties

Johnson & Johnson Reached $20.4 Million Settlement With Ohio Counties in Landmark Opioid Case

Tess Francke · October 9, 2019

Johnson & Johnson reached a $20.4 million settlement with Cuyahoga and Summit counties in Ohio. The company resolves all claims by the counties without admission of liability.

Legal Developments
A gavel illustration representing the J&J Opioid Damages in Oklahoma

Judge Orders J&J to Pay $572 Million to Remediate Opioid Damages in Oklahoma

Tess Francke · September 5, 2019

After a nearly two-month trial, Judge Thad Balkman of Cleveland County District Court ruled Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids. The company will pay $572 million for the community destruction caused by prescription painkillers.

Legal Developments
A gavel illustration representing the J&J Opioid Damages in Oklahoma

Judge Orders J&J to Pay $572 Million to Remediate Opioid Damages in Oklahoma

Tess Francke · September 5, 2019

After a nearly two-month trial, Judge Thad Balkman of Cleveland County District Court ruled Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids. The company will pay $572 million for the community destruction caused by prescription painkillers.

Legal Developments
A gavel illustration representing the J&J Opioid Damages in Oklahoma

Judge Orders J&J to Pay $572 Million to Remediate Opioid Damages in Oklahoma

Tess Francke · September 5, 2019

After a nearly two-month trial, Judge Thad Balkman of Cleveland County District Court ruled Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids. The company will pay $572 million for the community destruction caused by prescription painkillers.

Legal Developments
A gavel illustration representing the J&J Opioid Damages in Oklahoma

Judge Orders J&J to Pay $572 Million to Remediate Opioid Damages in Oklahoma

Tess Francke · September 5, 2019

After a nearly two-month trial, Judge Thad Balkman of Cleveland County District Court ruled Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids. The company will pay $572 million for the community destruction caused by prescription painkillers.

Legal Developments
A gavel illustration representing the J&J Opioid Damages in Oklahoma

Judge Orders J&J to Pay $572 Million to Remediate Opioid Damages in Oklahoma

Tess Francke · September 5, 2019

After a nearly two-month trial, Judge Thad Balkman of Cleveland County District Court ruled Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids. The company will pay $572 million for the community destruction caused by prescription painkillers.

Legal Developments
A gavel illustration representing the J&J Opioid Damages in Oklahoma

Judge Orders J&J to Pay $572 Million to Remediate Opioid Damages in Oklahoma

Tess Francke · September 5, 2019

After a nearly two-month trial, Judge Thad Balkman of Cleveland County District Court ruled Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids. The company will pay $572 million for the community destruction caused by prescription painkillers.

Legal Developments
A gavel illustration representing the J&J Opioid Damages in Oklahoma

Judge Orders J&J to Pay $572 Million to Remediate Opioid Damages in Oklahoma

Tess Francke · September 5, 2019

After a nearly two-month trial, Judge Thad Balkman of Cleveland County District Court ruled Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids. The company will pay $572 million for the community destruction caused by prescription painkillers.

Legal Developments
A gavel illustration representing the J&J Opioid Damages in Oklahoma

Judge Orders J&J to Pay $572 Million to Remediate Opioid Damages in Oklahoma

Tess Francke · September 5, 2019

After a nearly two-month trial, Judge Thad Balkman of Cleveland County District Court ruled Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids. The company will pay $572 million for the community destruction caused by prescription painkillers.

Legal Developments
little girl runs in field after news EPA may not ban a potentially harmful pesticide

The EPA Will Not Ban a Pesticide That Can Harm Kids’ Brains

Nicole Knight · August 28, 2019

The EPA has decided not to ban the pesticide chlorpyrifos despite evidence that the chemical harms children's brains. It is relevant to note that Dow Chemical, manufacturer of the chemical, donated significantly to the Trump administration's inaugural events.

Legal Developments
little girl runs in field after news EPA may not ban a potentially harmful pesticide

The EPA Will Not Ban a Pesticide That Can Harm Kids’ Brains

Nicole Knight · August 28, 2019

The EPA has decided not to ban the pesticide chlorpyrifos despite evidence that the chemical harms children's brains. It is relevant to note that Dow Chemical, manufacturer of the chemical, donated significantly to the Trump administration's inaugural events.

Legal Developments
little girl runs in field after news EPA may not ban a potentially harmful pesticide

The EPA Will Not Ban a Pesticide That Can Harm Kids’ Brains

Nicole Knight · August 28, 2019

The EPA has decided not to ban the pesticide chlorpyrifos despite evidence that the chemical harms children's brains. It is relevant to note that Dow Chemical, manufacturer of the chemical, donated significantly to the Trump administration's inaugural events.

Legal Developments
little girl runs in field after news EPA may not ban a potentially harmful pesticide

The EPA Will Not Ban a Pesticide That Can Harm Kids’ Brains

Nicole Knight · August 28, 2019

The EPA has decided not to ban the pesticide chlorpyrifos despite evidence that the chemical harms children's brains. It is relevant to note that Dow Chemical, manufacturer of the chemical, donated significantly to the Trump administration's inaugural events.

Legal Developments
little girl runs in field after news EPA may not ban a potentially harmful pesticide

The EPA Will Not Ban a Pesticide That Can Harm Kids’ Brains

Nicole Knight · August 28, 2019

The EPA has decided not to ban the pesticide chlorpyrifos despite evidence that the chemical harms children's brains. It is relevant to note that Dow Chemical, manufacturer of the chemical, donated significantly to the Trump administration's inaugural events.

Legal Developments
little girl runs in field after news EPA may not ban a potentially harmful pesticide

The EPA Will Not Ban a Pesticide That Can Harm Kids’ Brains

Nicole Knight · August 28, 2019

The EPA has decided not to ban the pesticide chlorpyrifos despite evidence that the chemical harms children's brains. It is relevant to note that Dow Chemical, manufacturer of the chemical, donated significantly to the Trump administration's inaugural events.

Legal Developments
little girl runs in field after news EPA may not ban a potentially harmful pesticide

The EPA Will Not Ban a Pesticide That Can Harm Kids’ Brains

Nicole Knight · August 28, 2019

The EPA has decided not to ban the pesticide chlorpyrifos despite evidence that the chemical harms children's brains. It is relevant to note that Dow Chemical, manufacturer of the chemical, donated significantly to the Trump administration's inaugural events.

Legal Developments
little girl runs in field after news EPA may not ban a potentially harmful pesticide

The EPA Will Not Ban a Pesticide That Can Harm Kids’ Brains

Nicole Knight · August 28, 2019

The EPA has decided not to ban the pesticide chlorpyrifos despite evidence that the chemical harms children's brains. It is relevant to note that Dow Chemical, manufacturer of the chemical, donated significantly to the Trump administration's inaugural events.

Legal Developments
A photo of J&J's talcum powder products in relation to a recent lawsuit involving Claire's.

Seven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others

James Parker · August 1, 2019

Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.

Legal Developments
A photo of J&J's talcum powder products in relation to a recent lawsuit involving Claire's.

Seven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others

James Parker · August 1, 2019

Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.

Legal Developments
A photo of J&J's talcum powder products in relation to a recent lawsuit involving Claire's.

Seven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others

James Parker · August 1, 2019

Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.

Legal Developments
A photo of J&J's talcum powder products in relation to a recent lawsuit involving Claire's.

Seven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others

James Parker · August 1, 2019

Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.

Legal Developments
A photo of J&J's talcum powder products in relation to a recent lawsuit involving Claire's.

Seven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others

James Parker · August 1, 2019

Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.

Legal Developments
A photo of J&J's talcum powder products in relation to a recent lawsuit involving Claire's.

Seven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others

James Parker · August 1, 2019

Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.

Legal Developments
A photo of J&J's talcum powder products in relation to a recent lawsuit involving Claire's.

Seven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others

James Parker · August 1, 2019

Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.

Legal Developments
A photo of J&J's talcum powder products in relation to a recent lawsuit involving Claire's.

Seven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others

James Parker · August 1, 2019

Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.

Legal Developments
A photo of a mesh fence to resemble the latest transvaginal mesh trial where testimony stated that J&J Mesh Misleads Consumers with Marketing Tactics.

Marketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh

James Parker · July 31, 2019

In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.

Legal Developments
A photo of a mesh fence to resemble the latest transvaginal mesh trial where testimony stated that J&J Mesh Misleads Consumers with Marketing Tactics.

Marketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh

James Parker · July 31, 2019

In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.

Legal Developments
A photo of a mesh fence to resemble the latest transvaginal mesh trial where testimony stated that J&J Mesh Misleads Consumers with Marketing Tactics.

Marketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh

James Parker · July 31, 2019

In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.

Legal Developments
A photo of a mesh fence to resemble the latest transvaginal mesh trial where testimony stated that J&J Mesh Misleads Consumers with Marketing Tactics.

Marketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh

James Parker · July 31, 2019

In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.

Legal Developments
A photo of a mesh fence to resemble the latest transvaginal mesh trial where testimony stated that J&J Mesh Misleads Consumers with Marketing Tactics.

Marketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh

James Parker · July 31, 2019

In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.

Legal Developments
A photo of a mesh fence to resemble the latest transvaginal mesh trial where testimony stated that J&J Mesh Misleads Consumers with Marketing Tactics.

Marketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh

James Parker · July 31, 2019

In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.

Legal Developments
A photo of a mesh fence to resemble the latest transvaginal mesh trial where testimony stated that J&J Mesh Misleads Consumers with Marketing Tactics.

Marketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh

James Parker · July 31, 2019

In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.

Legal Developments
A photo of a mesh fence to resemble the latest transvaginal mesh trial where testimony stated that J&J Mesh Misleads Consumers with Marketing Tactics.

Marketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh

James Parker · July 31, 2019

In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.

Legal Developments
A photo of wheat representing the $2 billion Roundup verdict reduced.

$2 Billion Verdict Reduced in Roundup Cancer Case

Lauren Styx · July 29, 2019

In May, a jury awarded the amount of $2 billion in punitive damages and $55 million in compensatory damages to a California couple who developed cancer after years of exposure to Roundup weedkiller. Last week, the California judge significantly reduced the award in this historic Roundup cancer case.

Legal Developments
A photo of wheat representing the $2 billion Roundup verdict reduced.

$2 Billion Verdict Reduced in Roundup Cancer Case

Lauren Styx · July 29, 2019

In May, a jury awarded the amount of $2 billion in punitive damages and $55 million in compensatory damages to a California couple who developed cancer after years of exposure to Roundup weedkiller. Last week, the California judge significantly reduced the award in this historic Roundup cancer case.

Legal Developments
A photo of wheat representing the $2 billion Roundup verdict reduced.

$2 Billion Verdict Reduced in Roundup Cancer Case

Lauren Styx · July 29, 2019

In May, a jury awarded the amount of $2 billion in punitive damages and $55 million in compensatory damages to a California couple who developed cancer after years of exposure to Roundup weedkiller. Last week, the California judge significantly reduced the award in this historic Roundup cancer case.

Legal Developments
A photo of wheat representing the $2 billion Roundup verdict reduced.

$2 Billion Verdict Reduced in Roundup Cancer Case

Lauren Styx · July 29, 2019

In May, a jury awarded the amount of $2 billion in punitive damages and $55 million in compensatory damages to a California couple who developed cancer after years of exposure to Roundup weedkiller. Last week, the California judge significantly reduced the award in this historic Roundup cancer case.

Legal Developments
A photo of wheat representing the $2 billion Roundup verdict reduced.

$2 Billion Verdict Reduced in Roundup Cancer Case

Lauren Styx · July 29, 2019

In May, a jury awarded the amount of $2 billion in punitive damages and $55 million in compensatory damages to a California couple who developed cancer after years of exposure to Roundup weedkiller. Last week, the California judge significantly reduced the award in this historic Roundup cancer case.

Legal Developments
A photo of wheat representing the $2 billion Roundup verdict reduced.

$2 Billion Verdict Reduced in Roundup Cancer Case

Lauren Styx · July 29, 2019

In May, a jury awarded the amount of $2 billion in punitive damages and $55 million in compensatory damages to a California couple who developed cancer after years of exposure to Roundup weedkiller. Last week, the California judge significantly reduced the award in this historic Roundup cancer case.

Legal Developments
A photo of wheat representing the $2 billion Roundup verdict reduced.

$2 Billion Verdict Reduced in Roundup Cancer Case

Lauren Styx · July 29, 2019

In May, a jury awarded the amount of $2 billion in punitive damages and $55 million in compensatory damages to a California couple who developed cancer after years of exposure to Roundup weedkiller. Last week, the California judge significantly reduced the award in this historic Roundup cancer case.

Legal Developments
A photo of wheat representing the $2 billion Roundup verdict reduced.

$2 Billion Verdict Reduced in Roundup Cancer Case

Lauren Styx · July 29, 2019

In May, a jury awarded the amount of $2 billion in punitive damages and $55 million in compensatory damages to a California couple who developed cancer after years of exposure to Roundup weedkiller. Last week, the California judge significantly reduced the award in this historic Roundup cancer case.

Legal Developments
Photo of woman holding opioids after Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids.

Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids

James Parker · June 25, 2019

Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.

Legal Developments
Photo of woman holding opioids after Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids.

Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids

James Parker · June 25, 2019

Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.

Legal Developments
Photo of woman holding opioids after Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids.

Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids

James Parker · June 25, 2019

Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.

Legal Developments
Photo of woman holding opioids after Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids.

Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids

James Parker · June 25, 2019

Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.

Legal Developments
Photo of woman holding opioids after Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids.

Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids

James Parker · June 25, 2019

Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.

Legal Developments
Photo of woman holding opioids after Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids.

Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids

James Parker · June 25, 2019

Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.

Legal Developments
Photo of woman holding opioids after Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids.

Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids

James Parker · June 25, 2019

Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.

Legal Developments
Photo of woman holding opioids after Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids.

Oklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids

James Parker · June 25, 2019

Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.

Legal Developments
A photo of a doctor making note of a patient's adverse event for reporting, which would be mandatory under the Medical Device Guardians Act.

Guardians Act Would Require Doctors to File Adverse Event Reports

Nicole Knight · June 4, 2019

A new bill was introduced in the House of Representatives, inspired by Dr. Amy Reed whose cancer was spread by a medical device called a power morcellator. The Medical Device Guardians Act would require doctors to report unsafe devices to the U.S. Food and Drug Administration (FDA).

Legal Developments
A photo of a doctor making note of a patient's adverse event for reporting, which would be mandatory under the Medical Device Guardians Act.

Guardians Act Would Require Doctors to File Adverse Event Reports

Nicole Knight · June 4, 2019

A new bill was introduced in the House of Representatives, inspired by Dr. Amy Reed whose cancer was spread by a medical device called a power morcellator. The Medical Device Guardians Act would require doctors to report unsafe devices to the U.S. Food and Drug Administration (FDA).

Legal Developments
A photo of a doctor making note of a patient's adverse event for reporting, which would be mandatory under the Medical Device Guardians Act.

Guardians Act Would Require Doctors to File Adverse Event Reports

Nicole Knight · June 4, 2019

A new bill was introduced in the House of Representatives, inspired by Dr. Amy Reed whose cancer was spread by a medical device called a power morcellator. The Medical Device Guardians Act would require doctors to report unsafe devices to the U.S. Food and Drug Administration (FDA).

Legal Developments
A photo of a doctor making note of a patient's adverse event for reporting, which would be mandatory under the Medical Device Guardians Act.

Guardians Act Would Require Doctors to File Adverse Event Reports

Nicole Knight · June 4, 2019

A new bill was introduced in the House of Representatives, inspired by Dr. Amy Reed whose cancer was spread by a medical device called a power morcellator. The Medical Device Guardians Act would require doctors to report unsafe devices to the U.S. Food and Drug Administration (FDA).

Legal Developments
A photo of a doctor making note of a patient's adverse event for reporting, which would be mandatory under the Medical Device Guardians Act.

Guardians Act Would Require Doctors to File Adverse Event Reports

Nicole Knight · June 4, 2019

A new bill was introduced in the House of Representatives, inspired by Dr. Amy Reed whose cancer was spread by a medical device called a power morcellator. The Medical Device Guardians Act would require doctors to report unsafe devices to the U.S. Food and Drug Administration (FDA).

Legal Developments
A photo of a doctor making note of a patient's adverse event for reporting, which would be mandatory under the Medical Device Guardians Act.

Guardians Act Would Require Doctors to File Adverse Event Reports

Nicole Knight · June 4, 2019

A new bill was introduced in the House of Representatives, inspired by Dr. Amy Reed whose cancer was spread by a medical device called a power morcellator. The Medical Device Guardians Act would require doctors to report unsafe devices to the U.S. Food and Drug Administration (FDA).

Legal Developments
A photo of a doctor making note of a patient's adverse event for reporting, which would be mandatory under the Medical Device Guardians Act.

Guardians Act Would Require Doctors to File Adverse Event Reports

Nicole Knight · June 4, 2019

A new bill was introduced in the House of Representatives, inspired by Dr. Amy Reed whose cancer was spread by a medical device called a power morcellator. The Medical Device Guardians Act would require doctors to report unsafe devices to the U.S. Food and Drug Administration (FDA).

Legal Developments
A photo of a doctor making note of a patient's adverse event for reporting, which would be mandatory under the Medical Device Guardians Act.

Guardians Act Would Require Doctors to File Adverse Event Reports

Nicole Knight · June 4, 2019

A new bill was introduced in the House of Representatives, inspired by Dr. Amy Reed whose cancer was spread by a medical device called a power morcellator. The Medical Device Guardians Act would require doctors to report unsafe devices to the U.S. Food and Drug Administration (FDA).

Legal Developments